S&P 500   5,069.53
DOW   39,069.23
QQQ   436.55
These 2 carnivore dining stocks gaining on the Ozempic craze
Energy Storage Trend Ignites Frenzy Over Vanadium Supply (Ad)
This healthcare stock making a buzz with 160% growth
This infrastructure construction stock: Is it ready to pop?
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
How major US stock indexes fared Monday, 2/26/2024
Is Roku worth a second look after the earnings panic selloff?
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Is The Trade Desk signaling the rebound of digital advertising?
bluebird bio stock is ripe for a 400% institutional short squeeze
S&P 500   5,069.53
DOW   39,069.23
QQQ   436.55
These 2 carnivore dining stocks gaining on the Ozempic craze
Energy Storage Trend Ignites Frenzy Over Vanadium Supply (Ad)
This healthcare stock making a buzz with 160% growth
This infrastructure construction stock: Is it ready to pop?
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
How major US stock indexes fared Monday, 2/26/2024
Is Roku worth a second look after the earnings panic selloff?
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Is The Trade Desk signaling the rebound of digital advertising?
bluebird bio stock is ripe for a 400% institutional short squeeze
S&P 500   5,069.53
DOW   39,069.23
QQQ   436.55
These 2 carnivore dining stocks gaining on the Ozempic craze
Energy Storage Trend Ignites Frenzy Over Vanadium Supply (Ad)
This healthcare stock making a buzz with 160% growth
This infrastructure construction stock: Is it ready to pop?
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
How major US stock indexes fared Monday, 2/26/2024
Is Roku worth a second look after the earnings panic selloff?
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Is The Trade Desk signaling the rebound of digital advertising?
bluebird bio stock is ripe for a 400% institutional short squeeze
S&P 500   5,069.53
DOW   39,069.23
QQQ   436.55
These 2 carnivore dining stocks gaining on the Ozempic craze
Energy Storage Trend Ignites Frenzy Over Vanadium Supply (Ad)
This healthcare stock making a buzz with 160% growth
This infrastructure construction stock: Is it ready to pop?
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
How major US stock indexes fared Monday, 2/26/2024
Is Roku worth a second look after the earnings panic selloff?
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Is The Trade Desk signaling the rebound of digital advertising?
bluebird bio stock is ripe for a 400% institutional short squeeze

Eloxx Pharmaceuticals (ELOX) Insider Trading & Ownership

$0.87
0.00 (0.00%)
(As of 02/26/2024 ET)

Eloxx Pharmaceuticals (NASDAQ:ELOX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
20.20%
Number Of
Insiders Buying
(Last 3 Years)
3
Amount Of
Insider Buying
(Last 3 Years)
$11.37 M
Number Of
Insiders Selling
(Last 3 Years)
0
Get ELOX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Eloxx Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

ELOX Insider Buying and Selling by Quarter


Eloxx Pharmaceuticals Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/29/2021Daniel E GeffkenCFOBuy50,000$0.72$36,000.00  
5/13/2021Pontifax Management 4 G.P. (20Major ShareholderBuy5,925,925$1.35$7,999,998.75  
5/13/2021Rajesh B ParekhDirectorBuy2,466,666$1.35$3,329,999.10  
(Data available from 1/1/2013 forward)












ELOX Insider Trading Activity - Frequently Asked Questions

Who is on Eloxx Pharmaceuticals's Insider Roster?

The list of insiders at Eloxx Pharmaceuticals includes Daniel E Geffken, Pontifax Management 4 G.P. (20, and Rajesh B Parekh. Learn more on insiders at ELOX.

What percentage of Eloxx Pharmaceuticals stock is owned by insiders?

20.20% of Eloxx Pharmaceuticals stock is owned by insiders. Learn more on ELOX's insider holdings.


More Insider Trading Tools from MarketBeat

This page (NASDAQ:ELOX) was last updated on 2/27/2024 by MarketBeat.com Staff